Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
EBITDA Growth
-12.92%
TTM · Period ending:
TEVA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-12.92%period ending
Latest reported-12.92%period ending
TEVA TTM EBITDA YoY % (-55.00% → -12.92%)
Year-over-year change
High-resolution chart · PNG
TEVA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -12.9238% | |
| 27.3364% | |
| 100.3593% | |
| 91.4074% | |
| 21.8405% | |
| -18.965% | |
| -57.3653% | |
| 11.6318% | |
| 26.947% | |
| 61.2723% | |
| 393.947% | |
| 12.6708% | |
| 0.8377% | |
| 9.2273% | |
| -73.3714% | |
| -58.3333% | |
| 268.1338% | |
| 221.5541% | |
| 275.1765% | |
| 327.1605% | |
| -143.8272% | |
| -180.2603% | |
| -192.8454% | |
| 15.4993% | |
| 311.2469% | |
| 424.6479% | |
| 106.4262% | |
| 77.546% | |
| 85.8461% | |
| 96.0271% | |
| 105.9315% | |
| -262.2222% | |
| -240.3612% | |
| -534.9559% | |
| -542.1644% | |
| -150.2028% | |
| -148.8118% | |
| -46.9411% | |
| -41.78% | |
| -12.8975% | |
| -5.179% | |
| 20.1979% | |
| 6.6654% | |
| 11.8798% | |
| 9.6871% | |
| 45.923% | |
| 55.6% | |
| 54.1908% | |
| 127.8383% | |
| -6.5361% | |
| -9.8403% | |
| -20.5954% | |
| -56.4994% | |
| 14.5846% | |
| 30.0938% | |
| 34.7684% | |
| 56.6698% | |
| -32.8583% | |
| -38.4488% | |
| -28.0957% | |
| -15.5073% | |
| 41.3525% | |
| 55.634% | |
| 116.3369% | |
| 119.6439% | |
| 125.3567% | |
| 90.1709% | |
| -37.2892% | |
| -44.3948% | |
| -50.8604% | |
| -43.8272% | |
| 18.9719% | |
| 15.5137% | |
| 14.1672% | |
| 13.9686% | |
| 8.0645% | |
| 40.9406% | |
| 92.6611% | |
| 80.1768% | |
| 82.0833% | |
| 42.6563% | |
| 6.7372% | |
| -21.1521% | |
| -24.2453% | |
| -18.3811% | |
| -18.3257% | |
| 86.6321% | |
| 110.7623% | |
| 115.7957% | |
| 174.9958% | |
| 84.1603% | |
| 79.5682% | |
| 71.7337% | |
| 41.3741% | |
| 33.795% | |
| 6.2588% | |
| 7.1043% | |
| -0.4249% | |
| -1.323% | |
| 55.971% |